Inositol Alleviates Pulmonary Fibrosis by Promoting Autophagy via Inhibiting the HIF-1α-SLUG Axis in Acute Respiratory Distress Syndrome. (23rd December 2022)

• Record Type: Journal Article
• Authors: Liang, Yufeng; Xu, Yingyi; Lu, Bingtai; Huang, Yuanming; Xu, Shuman; Xie, Junjie; Liu, Ming; Che, Di; Ma, Liuheyi; Tao, Jianping; Hong, Jie; Zhang, Jianhui; Situ, Xun; Ou, XinXu; Chen, Lihe; Li, Yang; Zhang, Lihong; Wu, Zhiyuan
• Other Names: Muddassir Ali Muhammad Academic Editor.
• Is Part Of: Oxidative medicine and cellular longevity. Volume 2022(2022)
• Publication Date: 2022-12-23
• Subjects: Oxidative stress -- Periodicals; Cells -- Aging -- Periodicals; Cells -- Aging; Oxidative stress; Oxidative Stress -- Periodicals; Cell Aging -- Periodicals; Periodicals; 611.0181
• DOI: 10.1155/2022/1030238
• Languages: English
• ISSNs: 1942-0900

Abstract

Abstract : The effective remission of acute respiratory distress syndrome- (ARDS-) caused pulmonary fibrosis determines the recovery of lung function. Inositol can relieve lung injuries induced by ARDS. However, the mechanism of myo-inositol in the development of ARDS is unclear, which limits its use in the clinic. We explored the role and mechanism of myo-inositol in the development of ARDS by using an in vitro lipopolysaccharide- (LPS-) established alveolar epithelial cell inflammation model and an in vivo ARDS mouse model. Our results showed that inositol can alleviate the progression of pulmonary fibrosis. More significantly, we found that inositol can induce autophagy to inhibit the progression pulmonary fibrosis caused by ARDS. In order to explore the core regulators of ARDS affected by inositol, mRNA-seq sequencing was performed. Those results showed that transcription factor HIF-1 α can regulate the expression of SLUG, which in turn can regulate the key gene E-Cadherin involved in cell epithelial-mesenchymal transition (EMT) as well as N-cadherin expression, and both were regulated by inositol. Our results suggest that inositol activates autophagy to inhibit EMT progression induced by the HIF-1 α /SLUG signaling pathway in ARDS, and thereby alleviates pulmonary fibrosis.